Contact Us Site Map Request More Info
 
About OKTO   Eye Care Professionals   Patients   News and Press
Home     News and Press
Full Listing
Archive


 

OKTO Announces the Addition of Erik Melling as Director of Sales-U.S.

COSTA MESA, California – October 1, 2002 – OKTO Ophtho, the premier developer and distributor of specialty technologies for eye surgery, announced today the addition of Erik Melling to the OKTO management team as Director of Sales-U.S. This new appointment is effective immediately.

Melling, 34, is a recognized, industry-wide leader in sales leadership and management in the ophthalmic distribution sector. Erik began his career in surgical sales in 1991. He has extensive, surgical sales experience and expertise in anterior segment ophthalmic surgery, microsurgery and surgical instrumentation.

In 1992, Melling teamed up with IOP, Inc. (Costa Mesa, CA) as an independent surgical representative, and immediately established himself as a revenue leader, industry expert and spiritual leader. In October of 1998, Erik joined IOP full-time as the Director of Sales. Revenues under his leadership at IOP, Inc. expanded more than 200% within the United States.

His new position with the company will allow the company and customers to benefit from Erik’s sales and surgical expertise on a national level. He will be responsible for managing; the hiring and promotion of all sales personnel; establishment of territorial revenue goals; the formulation and implementation of company-wide, revenue-generating incentive plans; and the development of sales plans and strategies.

Erik graduated in 1991 from George Mason University with a B.S. degree in Business/Marketing.

About OKTO

Founded in 2000, OKTO Ophtho develops and commercializes specialized, leading-edge surgical technologies for eye surgery. OKTO’s purpose is to develop surgical solutions that improve the quality of life for patients, elevate the performance and productivity of eye care professionals, and lower costs to the provider.

OKTO currently holds leadership positions with surgical devices for oculoplastic surgeries and bio-implant technologies for ocular surface/ophthalmic reconstructive surgeries.

Media Contact:

pr@oktoophtho.com